Gabapentin Dementia Lawsuit in New Jersey

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Written By
People's Justice Legal Research Team

Statute of Limitations

New Jersey: 2 years for personal injury (N.J.S.A. § 2A:14-2). Discovery rule applies — the limitations period begins when the plaintiff knew or should have known of the injury and its connection to gabapentin.

2 years from discovery of injury

Filing Venue

Where to File in New Jersey

New Jersey gabapentin cases may be filed in the District of New Jersey (Newark, Trenton, or Camden) or in New Jersey Superior Court. The District of New Jersey has managed major pharmaceutical MDLs including Vioxx. Middlesex County's mass tort program efficiently coordinates pharmaceutical claims. New Jersey's Product Liability Act (N.J.S.A. § 2A:58C-1 et seq.) provides statutory framework for design defect and failure-to-warn claims. The state follows modified comparative fault and does not cap compensatory damages.

New Jersey Data

Exposure in New Jersey

Source: IQVIA / NJ PDMP data

Source: NJ pharmaceutical industry data

Source: New Jersey Judiciary, mass tort program

FAQ

Frequently Asked Questions

See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
Back to Gabapentin Dementia Lawsuit Lawsuit Overview